Episode 21: Neoadjuvant degarelix with or without apalutamide prior to surgery for high-risk prostate cancer: results of the phase II ARNEO trial
This content is accessible exclusively to verified healthcare professionals.
If you are a registered user, please log in here.
If you do not yet have an account, please register here.
Thank you for your understanding.